Sylvia A. Ashamallah

588 total citations
17 papers, 465 citations indexed

About

Sylvia A. Ashamallah is a scholar working on Surgery, Genetics and Oncology. According to data from OpenAlex, Sylvia A. Ashamallah has authored 17 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 5 papers in Genetics and 5 papers in Oncology. Recurrent topics in Sylvia A. Ashamallah's work include Pancreatic function and diabetes (7 papers), Mesenchymal stem cell research (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Sylvia A. Ashamallah is often cited by papers focused on Pancreatic function and diabetes (7 papers), Mesenchymal stem cell research (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Sylvia A. Ashamallah collaborates with scholars based in Egypt, Oman and United States. Sylvia A. Ashamallah's co-authors include Mohamed E. Shaker, Maha E. Houssen, Mohamed A. Ghoneim, Ayman Refaie, Mahmoud M. Zakaria, M. Ismail, Sherry M. Khater, Mahmoud M. Gabr, Nagwa El‐Badri and Mona Abdel Rahim and has published in prestigious journals such as Food and Chemical Toxicology, BioMed Research International and Toxicology Letters.

In The Last Decade

Sylvia A. Ashamallah

16 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvia A. Ashamallah Egypt 12 224 164 144 106 76 17 465
Gisela Pachón-Peña United States 8 112 0.5× 170 1.0× 208 1.4× 59 0.6× 17 0.2× 11 472
Rui Xi Li China 8 79 0.4× 247 1.5× 71 0.5× 43 0.4× 45 0.6× 9 537
Peihua Wang China 12 87 0.4× 85 0.5× 50 0.3× 53 0.5× 47 0.6× 29 372
Kristen J. Skvorak United States 17 379 1.7× 365 2.2× 129 0.9× 49 0.5× 10 0.1× 22 831
Rihua Zhang China 14 52 0.2× 309 1.9× 18 0.1× 77 0.7× 54 0.7× 24 501
Junguo Cao China 10 33 0.1× 205 1.3× 40 0.3× 69 0.7× 44 0.6× 20 361
Faji Yang China 12 101 0.5× 187 1.1× 53 0.4× 166 1.6× 30 0.4× 30 504
Jie Kuang China 12 164 0.7× 244 1.5× 12 0.1× 160 1.5× 135 1.8× 27 614
Shasha Lv China 13 159 0.7× 444 2.7× 174 1.2× 42 0.4× 43 0.6× 31 767

Countries citing papers authored by Sylvia A. Ashamallah

Since Specialization
Citations

This map shows the geographic impact of Sylvia A. Ashamallah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia A. Ashamallah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia A. Ashamallah more than expected).

Fields of papers citing papers by Sylvia A. Ashamallah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia A. Ashamallah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia A. Ashamallah. The network helps show where Sylvia A. Ashamallah may publish in the future.

Co-authorship network of co-authors of Sylvia A. Ashamallah

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia A. Ashamallah. A scholar is included among the top collaborators of Sylvia A. Ashamallah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia A. Ashamallah. Sylvia A. Ashamallah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Arafa, Mohammad, et al.. (2022). Correlation of PD-L1 immunohistochemical expression with microsatellite instability and p53 status in endometrial carcinoma. European Journal of Obstetrics & Gynecology and Reproductive Biology X. 16. 100172–100172. 3 indexed citations
2.
Ghoneim, Mohamed A., Mahmoud M. Gabr, Ayman Refaie, et al.. (2022). Transplantation of insulin-producing cells derived from human mesenchymal stromal/stem cells into diabetic humanized mice. Stem Cell Research & Therapy. 13(1). 350–350. 11 indexed citations
3.
Bar, Fatma M. Abdel, et al.. (2021). Anti-Obesity and Antihyperlipidemic Effects of Musa cavendishii. Records of Natural Products. 212–224.
4.
Gabr, Mahmoud M., Mahmoud M. Zakaria, Ayman Refaie, et al.. (2020). PRDX6 Promotes the Differentiation of Human Mesenchymal Stem (Stromal) Cells to Insulin‐Producing Cells. BioMed Research International. 2020(1). 7103053–7103053. 5 indexed citations
5.
Arafa, Mohammad, et al.. (2019). Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma. Journal of Pathology and Translational Medicine. 53(3). 164–172. 12 indexed citations
6.
Gabr, Mahmoud M., Mahmoud M. Zakaria, Ayman Refaie, et al.. (2018). Insulin-producing Cells from Adult Human Bone Marrow Mesenchymal Stromal Cells Could Control Chemically Induced Diabetes in Dogs. Cell Transplantation. 27(6). 937–947. 19 indexed citations
7.
Gabr, Mahmoud M., Mahmoud M. Zakaria, Ayman Refaie, et al.. (2017). From Human Mesenchymal Stem Cells to Insulin-Producing Cells: Comparison between Bone Marrow- and Adipose Tissue-Derived Cells. BioMed Research International. 2017. 1–9. 35 indexed citations
8.
Shaker, Mohamed E., et al.. (2016). Inhibition of the JAK/STAT pathway by ruxolitinib ameliorates thioacetamide-induced hepatotoxicity. Food and Chemical Toxicology. 96. 290–301. 20 indexed citations
9.
Shaker, Mohamed E., Sylvia A. Ashamallah, & Mohamed El‐Mesery. (2016). The novel c-Met inhibitor capmatinib mitigates diethylnitrosamine acute liver injury in mice. Toxicology Letters. 261. 13–25. 14 indexed citations
10.
Gabr, Mahmoud M., Mahmoud M. Zakaria, Ayman Refaie, et al.. (2015). Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Insulin-Producing Cells: Evidence for Further Maturation In Vivo. BioMed Research International. 2015. 1–10. 26 indexed citations
11.
Shaker, Mohamed E., et al.. (2014). The novel Janus kinase inhibitor ruxolitinib confers protection against carbon tetrachloride-induced hepatotoxicity via multiple mechanisms. Chemico-Biological Interactions. 220. 116–127. 18 indexed citations
12.
Gabr, Mahmoud M., Mahmoud M. Zakaria, Ayman Refaie, et al.. (2014). Generation of Insulin-Producing Cells from Human Bone Marrow-Derived Mesenchymal Stem Cells: Comparison of Three Differentiation Protocols. BioMed Research International. 2014. 1–9. 33 indexed citations
13.
Shaker, Mohamed E., Sylvia A. Ashamallah, & Maha E. Houssen. (2014). Celastrol ameliorates murine colitis via modulating oxidative stress, inflammatory cytokines and intestinal homeostasis. Chemico-Biological Interactions. 210. 26–33. 87 indexed citations
14.
Hussein, Abdelaziz M., et al.. (2014). Pancreatic Injury Secondary to Renal Ischemia/Reperfusion (I/R) Injury: Possible Role of Oxidative Stress. Physiological Research. 63(1). 47–55. 15 indexed citations
15.
Ashamallah, Sylvia A., et al.. (2013). Atypical Meningioma: A Study of Prognostic Factors. World Neurosurgery. 80(5). 549–553. 77 indexed citations
16.
Gabr, Mahmoud M., Mahmoud M. Zakaria, Ayman Refaie, et al.. (2013). Insulin-Producing Cells from Adult Human Bone Marrow Mesenchymal Stem Cells Control Streptozotocin-Induced Diabetes in Nude Mice. Cell Transplantation. 22(1). 133–145. 86 indexed citations
17.
Ashamallah, Sylvia A., et al.. (2012). Atypical meningioma: a study of prognostic factors.. 8(Issue 1-2). 50–55. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026